Closed System Bioprocessing Market To Reach $21.37 Billion By 2033

Closed System Bioprocessing Market Growth & Trends

The global closed system bioprocessing market size is projected to reach USD 21.37 billion by 2033, growing at a CAGR of 8.90% from 2026 to 2033, according to a new report by Grand View Research, Inc. The global market is expanding as biopharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and research institutions increasingly adopt sterile, automated processing environments to enhance product safety and operational efficiency. The growing demand for biologics, cell and gene therapies, and vaccines is driving this expansion, with closed system technologies gradually replacing open and manual processes to minimize contamination risks and ensure regulatory compliance.

Advances in single-use technologies, automated bioreactors, closed cell expansion systems, and integrated fluid management platforms are driving demand for closed system bioprocessing. Innovations like real-time sensors, digital control systems, robotics, and data analytics enhance process control, reduce human intervention, and improve efficiency across upstream and downstream operations.

Integrating closed system bioprocessing with MES, QMS, and continuous manufacturing improves reliability, traceability, and regulatory compliance, while optimizing yield, reducing batch failures, and supporting flexible small-batch and personalized therapies.

Biopharma companies, CMDOs, and biotech firms increasingly rely on closed system bioprocessing for contamination-free manufacturing, streamlined scale-up, regulatory compliance, and cost efficiency. With growing demand for biologics and advanced therapies, these technologies remain crucial for sustainable, innovative biomanufacturing.

 Request a free sample copy or view report summary: Closed System Bioprocessing Market Report

Closed System Bioprocessing Market Report Highlights

• By product, bioreactors dominated the market with a share of 35.67% in 2025. High demand is driven by the increasing adoption of closed and single-use bioreactor systems that ensure sterile processing environments, improve scalability, reduce contamination risks, and support efficient upstream biomanufacturing for biologics, cell therapies, and vaccine production.

• By application, biopharmaceutical production led the market in 2025 with a share of 41.55%, owing to the growing need for contamination-free, compliant, and scalable manufacturing processes for monoclonal antibodies, recombinant proteins, vaccines, and advanced therapies.

• By end use, pharmaceutical & biotech companies held the largest market share of 53.78% in 2025, supported by significant investments in biologics development, expansion of advanced therapy pipelines, and increased reliance on closed system platforms to optimize manufacturing workflows, ensure product quality, and accelerate time-to-market.

Closed System Bioprocessing Market Segmentation

Grand View Research has segmented the global closed system bioprocessing market on the basis of product, application, end user, and region:

Closed System Bioprocessing Product Outlook (Revenue, USD Million, 2021 - 2033)

• Bioreactors

• Fermenters

• Mixing Systems

• Filtration Systems

• Others

Closed System Bioprocessing Application Outlook (Revenue, USD Million, 2021 - 2033)

• Biopharmaceutical Production

• Vaccine Manufacturing

• Cell And Gene Therapy

• Regenerative Medicine

• Others

Closed System Bioprocessing End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical & Biotech Companies

• Contract Manufacturing Organizations

• Research & Academic Institutes

Closed System Bioprocessing Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Closed System Bioprocessing Market

• Thermo Fisher Scientific

• Sartorius AG

• Merck KGaA

• GE Healthcare (Cytiva)

• Danaher Corporation

• Eppendorf AG

• Lonza Group

• Corning Incorporated

• Pall Corporation

• Applikon Biotechnology

• PBS Biotech

• Miltenyi Biotec

• Fujifilm Diosynth Biotechnologies